News
Researchers in the Ciulli group report a first study describing the idea of a macrocyclic PROTAC. The research was published in the prestigious chemistry journal Angewandte Chemie.
News
Researchers in the Ciulli group report a first study describing the idea of a macrocyclic PROTAC. The research was published in the prestigious chemistry journal Angewandte Chemie.
News
DEBRA is delighted to share that funding for a fourth year of the University of Dundee’s research into novel gene technology for treating Epidermolysis Bullosa (EB) has been agreed.
News
Two academic entrepreneurs from the division of Biological Chemistry and Drug Discovery have made the final of the Converge Challenge 2019.
News
School of Life Sciences researcher Professor David Horn will receive a £2.1 million Investigator Award from Wellcome to decode gene expression mechanisms in trypanosomes, pathogenic protozoa that cause a range of human and animal diseases.
News
Dr Susan Wyllie, Head of the Mode of Action (MoA) group, has been promoted to tenure track Principal Investigator in the School.
News
The University of Dundee has announced a new partnership with Eisai, one of the world’s leading research-based pharmaceutical companies.
News
Around 60 aspiring entrepreneurs from across Scotland’s Universities are now through to the next stage of Scotland’s leading academic enterprise programme.
News
An Alessi lab PhD student working closely with the Ciulli lab has published an improved HaloPROTAC method to induce post–translational knockdown of endogenous proteins.
News
Professor Alessio Ciulli is recognised as one of a handful of key players world-wide in opening up and pushing forward this exciting field of research and development.
News
Dr Robyn Hickerson and her team won the Research Staff Award at Venture 2019 competition.
News
The findings challenge a dogma that has persisted for more than 30 years.
News
A group of scientists at the University of Dundee have been honoured for putting an end to a promising piece of research.
News
Researchers at the University of Dundee have identified a new drug target in parasites that cause major neglected tropical diseases, a discovery that contributes towards a global drive to eliminate these diseases by 2030.